Promising Early Results for Goflikicept in Pericarditis

The novel IL-1 inhibitor goflikicept is effective and relatively safe in idiopathic recurrent pericarditis.

Related Keywords

Russia ,Petersburg ,Sankt Peterburg ,Valentina Myachikova ,Research Laboratory Of Autoimmune ,Novartis ,R Pharm International ,Journal Of The American College Cardiology ,Research Laboratory ,Autoinflammatory Diseases ,American College ,Biologic Therapy ,Pericarditis ,Pain Management ,Nonsteroidal Anti Inflammatory Drugs Nsaids ,Nonsteroidal Anti Inflammatory Drugs ,Nsaids ,Rug Nonsteroidal Anti Inflammatory ,Chest Pain ,Angina ,Angina Pectoris ,Cytokines ,Spain ,Chest ,Tnf Alpha ,Tumor Necrosis Factor Alpha ,Umor Necrosis Factor Tnf ,Achexin ,Achectin ,C Reactive Protein ,Corticost ,